Collagen News and Research

Latest Collagen News and Research

KGI scientists identify new gene regulator that keeps hearts healthy even under intense exercise

Providing a medical explanation for why exercise is good for the heart, a team of scientists from Brazil pursuing a study that started in Dr. Ian Phillips' lab at Keck Graduate Institute (KGI) has discovered a new gene regulator called MicroRNA 29 that keeps hearts healthy even under intense exercise.

3 Jun 2011

Covidien's PCOx mesh receives U.S. FDA 510(k) clearance and European CE Mark approval

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration has granted 510(k) clearance and the European regulatory authorities have granted the CE Mark to Parietex Optimized Composite mesh.

2 Jun 2011

STAAR Surgical's two new lens products receive CE Mark approval

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic lenses which go inside the eye, today announced two strategically important regulatory approvals.

1 Jun 2011

Loss of elasticity and protein breakdown cause pelvic organ prolapse

A gynecologist and a molecular biologist at UT Southwestern Medical Center have collaborated to show for the first time that pelvic organ prolapse - a condition in which the uterus, bladder or vagina protrude from the body - is caused by a combination of a loss of elasticity and a breakdown of proteins in the vaginal wall.

24 May 2011

Stony Brook University CFB establishes Biotechnology Commercialization Fund

The Center for Biotechnology (CFB) at Stony Brook University has established the Biotechnology Commercialization Fund to accelerate the development of promising biomedical technologies emerging from Stony Brook University.

21 May 2011

Cordis EXOSEAL Vascular Closure Device receives approval in the U.S.

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced the approval of the EXOSEAL Vascular Closure Device in the US. EXOSEAL incorporates a number of new advances in technology and simplicity of design to provide precise and secure extravascular arterial closure.

21 May 2011

Improved tissue grafts promote vascular growth in wound sites

Victims of third-degree burns and other traumatic injuries endure pain, disfigurement, invasive surgeries and a long time waiting for skin to grow back. Improved tissue grafts designed by Cornell scientists that promote vascular growth could hasten healing, encourage healthy skin to invade the wounded area and reduce the need for surgeries.

18 May 2011

New insight into skin hardening syndromes

Researchers from Boston University School of Medicine have discovered new details about the underlying mechanisms of skin hardening syndromes.

18 May 2011

Restrictive gadolinium-based contrast agent guidelines help prevent nephrogenic systemic fibrosis

A simple blood test may help prevent a serious complication associated with a contrast agent commonly used in MRI exams, according to a study published in the July issue of Radiology.

18 May 2011

$Avedro completes two Phase III corneal cross-linking studies in keratoconus, ectasia post-refractive surgery$

Avedro completes two Phase III corneal cross-linking studies in keratoconus, ectasia post-refractive surgery

Avedro, Inc. today announced the completion of all one-year follow-up visits for patients enrolled in its two multi-center Phase III studies evaluating the safety and efficacy of corneal collagen cross-linking for the treatment of progressive keratoconus and ectasia following refractive surgery.

18 May 2011

Scleroderma is an independent determinant for coronary calcification, study suggests

A new study by researchers in Hong Kong suggests that systemic sclerosis is an independent determinant for moderate to severe coronary calcification or atherosclerosis.

11 May 2011

NTC, Aldevron partner to manufacture first plasmid DNA-based genetic cosmetic

Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.

11 May 2011

Research suggests systemic sclerosis is an independent risk factor for atherosclerosis

A new study by researchers in Hong Kong suggests that systemic sclerosis is an independent determinant for moderate to severe coronary calcification or atherosclerosis. Conventional cardiovascular risk factors such as age and hypertension predispose patients with systemic sclerosis to plaque build-up in the heart arteries similar to the general population. Details of this study are now available in Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR).

10 May 2011

Ellman International launches Pelleve GlideSafe handpieces for wrinkle treatment

Ellman International, Inc., maker of the Pelleve Wrinkle Reduction System, a revolutionary skin tightening system for non-ablative skin rejuvenation, introduced its new family of GlideSafe™ handpieces this week at the American Society for Aesthetic Plastic Surgery's 44th Annual Meeting at the Boston Convention & Exhibition Center.

9 May 2011

Kensey Nash revenues decrease 7% to $18.6 million for third quarter fiscal 2011

Kensey Nash Corporation, a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its third quarter ended March 31, 2011.

6 May 2011

Cosmofrance introduces Dermasculpt microcannula for painless cosmetic injections

Cosmofrance Inc. introduces Dermasculpt a FDA-approved, FLEXIBLE blunt-tip microcannula for non-bruising & practically painless cosmetic injections.

5 May 2011

FibroGen announces proof-of-principle for FG-4592 Phase 2 study in hemodialysis patients

FibroGen, Inc., today announced proof-of-principle for oral anemia therapy FG-4592, a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, in end-stage renal disease patients receiving hemodialysis.

4 May 2011

STAAR Surgical receives CE Mark approval for nanoFLEX Collamer IOL lens

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEX Collamer Single Piece IOL which can be injected through a 2.2 mm incision with the nanoPOINT Injector System.

28 Apr 2011

New angle in cause of tuberculosis discovered - scientists hopeful for new therapy

In a new study published Monday, researchers from the US have isolated the enzyme that allows tuberculosis to destroy lung tissue. This discovery could speed the search for treatments.

26 Apr 2011

Scientists identify key enzyme that destroys lung tissue in TB

Scientists have identified a key enzyme responsible for destroying lung tissue in tuberculosis, they report today in the Journal of Clinical Investigation. Drugs that inhibit this enzyme are already available, meaning that the finding could lead quickly to new treatments.

26 Apr 2011

Collagen News and Research

Latest Collagen News and Research

KGI scientists identify new gene regulator that keeps hearts healthy even under intense exercise

Covidien's PCOx mesh receives U.S. FDA 510(k) clearance and European CE Mark approval

STAAR Surgical's two new lens products receive CE Mark approval

Loss of elasticity and protein breakdown cause pelvic organ prolapse

Stony Brook University CFB establishes Biotechnology Commercialization Fund

Cordis EXOSEAL Vascular Closure Device receives approval in the U.S.

Improved tissue grafts promote vascular growth in wound sites

New insight into skin hardening syndromes

Restrictive gadolinium-based contrast agent guidelines help prevent nephrogenic systemic fibrosis

Avedro completes two Phase III corneal cross-linking studies in keratoconus, ectasia post-refractive surgery

Scleroderma is an independent determinant for coronary calcification, study suggests

NTC, Aldevron partner to manufacture first plasmid DNA-based genetic cosmetic

Research suggests systemic sclerosis is an independent risk factor for atherosclerosis

Ellman International launches Pelleve GlideSafe handpieces for wrinkle treatment

Kensey Nash revenues decrease 7% to $18.6 million for third quarter fiscal 2011

Cosmofrance introduces Dermasculpt microcannula for painless cosmetic injections

FibroGen announces proof-of-principle for FG-4592 Phase 2 study in hemodialysis patients

STAAR Surgical receives CE Mark approval for nanoFLEX Collamer IOL lens

New angle in cause of tuberculosis discovered - scientists hopeful for new therapy

Scientists identify key enzyme that destroys lung tissue in TB

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Collagen News and Research

Latest Collagen News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in